Comparative effects of six probiotic strains on immune function in vitro

British Journal of Nutrition

Volumn 108, Issue 3, 2012, Pages 459-470

  Dong, Honglin ^a   Rowland, Ian ^a   Yaqoob, Parveen ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Cytokines; Immune function; Lymphocytes; Probiotics

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; NATURAL KILLER CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

BIFIDOBACTERIUM; BIOLOGICAL MARKERS; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; LACTOBACILLUS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PROBIOTICS;

EID: 84858150499     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511005824     Document Type: Article

References (65)

1. Isolauri E, Salminen S & Ouwehand AC (2004) Probiotics. Best Pract Res Clin Gastroenterol 18, 299-313. (Pubitemid 38444132)
2. Sleator RD & Hill C (2008) New frontiers in probiotic research. Lett Appl Microbiol 46, 143-147.
3. Paineau D, Carcano D, Leyer G, et al. (2008) Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol 53, 107-113. (Pubitemid 351659718)
4. Cross ML, Ganner A, Teilab D, et al. (2004) Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol Med Microbiol 42, 173-180. (Pubitemid 39208544)
5. Ghadimi D, Folster-Holst R, de Vrese M, et al. (2008) Effects of probiotic bacteria and their genomic DNA on T(H)1/ T(H)2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 213, 677-692.
6. Helwig U, Lammers KM, Rizzello F, et al. (2006) Lactobacilli, bifidobacteria and E. coli Nissle induce pro- and antiinflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol 12, 5978-5986. (Pubitemid 44608476)
7. Medina M, Izquierdo E, Ennahar S, et al. (2007) Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol 150, 531-538. (Pubitemid 350098744)
8. Shida K, Suzuki T, Kiyoshima-Shibata J, et al. (2006) Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin Vaccine Immunol 13, 997-1003. (Pubitemid 44518967)
9. Haller D, Blum S, Bode C, et al. (2000) Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun 68, 752-759. (Pubitemid 30056533)
10. Fink LN, Zeuthen LH, Christensen HR, et al. (2007) Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int Immunol 19, 1319-1327. (Pubitemid 350131338)
11. Castellazzi AM, Valsecchi C, Montagna L, et al. (2007) In vitro activation of mononuclear cells by two probiotics: Lactobacillus paracasei I 1688, Lactobacillus salivarius I 1794, and their mixture (PSMIX). Immunol Invest 36, 413-421. (Pubitemid 47254575)
12. Takeda K & Okumura K (2007) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr 137, 791S-793S. (Pubitemid 46397519)
13. Albers R, Antoine JM, Bourdet-Sicard R, et al. (2005) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94, 452-481. (Pubitemid 41404289)
14. Kankaanpaa P, Sutas Y, Salminen S, et al. (2003) Homogenates derived from probiotic bacteria provide down-regulatory signals for peripheral blood mononuclear cells. Food Chem 83, 269-277. (Pubitemid 36962893)
15. Zeuthen LH, Christensen HR & Frokiaer H (2006) Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin Vaccine Immunol 13, 365-375.
16. Salminen S, Collado MC, Isolauri E, et al. (2009) Microbial- host interactions: selecting the right probiotics and prebiotics for infants. Nestle Nutr Workshop Ser Pediatr Program 64, 201-217.
17. Lopez P, Gueimonde M, Margolles A, et al. (2010) Distinct Bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol 138, 157-165.
18. Dong H, Rowland I, Tuohy KM, et al. (2010) Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production. Clin Exp Immunol 161, 378-388.
19. Hessle C, Hanson LA & Wold AE (1999) Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 116, 276-282. (Pubitemid 29219725)
20. Drago L, Nicola L, Iemoli E, et al. (2010) Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model. BMC Res Notes 3, 44-48.
21. Foligne B, Nutten S, Grangette C, et al. (2007) Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 13, 236-243. (Pubitemid 46231326)
22. Mastrangeli G, Corinti S, Butteroni C, et al. (2009) Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses. Int Arch Allergy Immunol 150, 133-143.
23. Flinterman AE, Knol EF, van Ieperen-Van Dijk AG, et al. (2007) Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy. Int Arch Allergy Immunol 143, 237-244. (Pubitemid 46918467)
24. Kekkonen RA, Lummela N, Karjalainen H, et al. (2008) Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 14, 2029-2036. (Pubitemid 351795822)
25. + lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging. Exp Gerontol 34, 79-93. (Pubitemid 29085070)
26. Meyer AL, Micksche M, Herbacek I, et al. (2006) Daily intake of probiotic as well as conventional yogurt has a stimulating effect on cellular immunity in young healthy women. Ann Nutr Metab 50, 282-289. (Pubitemid 43829820)
27. Ozkan TB, Sahin E, Erdemir G, et al. (2007) Effect of Saccharomyces boulardii in children with acute gastroenteritis and its relationship to the immune response. J Int Med Res 35, 201-212. (Pubitemid 46831068)
28. de Vrese M, Winkler P, Rautenberg P, et al. (2005) Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 24, 481-491. (Pubitemid 41051901)
29. Garciapenarrubia P, Koster FT, Kelley RO, et al. (1989) Antibacterial activity of human natural-killer cells. J Exp Med 169, 99-113. (Pubitemid 19035545)
30. Olivares M, Diaz-Ropero MP, Sierra S, et al. (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23, 254-260. (Pubitemid 46367573)
31. Bunout D, Barrera G, Hirsch S, et al. (2004) Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. J Parenter Enter Nutr 28, 348-354. (Pubitemid 39121458)
32. Roller M, Clune Y, Collins K, et al. (2007) Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr 97, 676-684. (Pubitemid 46470676)
33. Spanhaak S, Havenaar R & Schaafsma G (1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52, 899-907. (Pubitemid 29008371)
34. Cox AJ, Pyne DB, Saunders PU, et al. (2010) Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med 44, 222-226.
35. Ishikawa H, Akedo I, Otani T, et al. (2005) Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer 116, 762-767. (Pubitemid 41099707)
36. de Roock S, van Elk M, van Dijk MEA, et al. (2010) Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 40, 103-110.
37. Kalliomaki M, Antoine JM, Herz U, et al. (2010) Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr 140, 713S-721S.
38. Weaver CT, Harrington LE, Mangan PR, et al. (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677-688. (Pubitemid 43867371)
39. Singh VK, Mehrotra S & Agarwal SS (1999) The paradigm of Th1 and Th2 cytokines - its relevance to autoimmunity and allergy. Immunol Res 20, 147-161.
40. Borchers AT, Selmi C, Meyers FJ, et al. (2009) Probiotics and immunity. J Gastroenterol 44, 26-46.
41. Kekkonen RA, Kajasto E, Miettinen M, et al. (2008) Probiotic Leuconostoc mesenteroides ssp cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production. World J Gastroenterol 14, 1192-1203. (Pubitemid 351356326)
42. Timmerman HM, Niers LEM, Ridwan BU, et al. (2007) Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr 26, 450-459. (Pubitemid 47091487)
43. Vissers YM, Snel J, Zuurendonk PF, et al. (2010) Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 59, 60-70.
44. Miettinen M, VuopioVarkila J & Varkila K (1996) Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 64, 5403-5405. (Pubitemid 26404010)
45. Hessle C, Andersson B & Wold AE (2000) Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 68, 3581-3586. (Pubitemid 30340461)
46. Hart AL, Lammers K, Brigidi P, et al. (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53, 1602-1609. (Pubitemid 39434103)
47. Lammers KM, Brigidi P, Vitali B, et al. (2003) Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 38, 165-172. (Pubitemid 37297842)
48. Niers LEM, Timmerman HM, Rijkers GT, et al. (2005) Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 35, 1481-1489.
49. Ji GE (2009) Probiotics in primary prevention of atopic dermatitis. In Food Factors for Health Promotion, pp. 117-128. Basel: Karger.
50. Clancy RL & Pang G (2007) Probiotics - industry myth or a practical reality? J Am Coll Nutr 26, 691S-694S.
51. Kaji R, Kiyoshima-Shibata J, Nagaoka M, et al. (2010) Bacterial teichoic acids reverse predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol 184, 3505-3513.
52. Ivory K, Chambers SJ, Pin C, et al. (2008) Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin Exp Allergy 38, 1282-1289. (Pubitemid 352019670)
53. Shima T, Fukushima K, Setoyama H, et al. (2008) Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria. FEMS Immunol Med Microbiol 52, 69-77.
54. Kobayashi T, Kato I, Nanno M, et al. (2010) Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis. Immunopharmacol Immunotoxicol 32, 116-124.
55. Matsumoto S (2008) Anti-inflammatroy effects of probiotic Lactobacillus casei strain Shirota in chronic intestinal inflammatory disorders. Int J Probiotics Prebiotics 3, 149-152.
56. Pena JA & Versalovic J (2003) Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol 5, 277-285. (Pubitemid 36511574)
57. Pessi T, Sutas Y, Hurme H, et al. (2000) Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30, 1804-1808. (Pubitemid 32011762)
58. Isolauri E, Arvola T, Sutas Y, et al. (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30, 1604-1610.
59. Kalliomaki M, Salminen S, Arvilommi H, et al. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079. (Pubitemid 32322538)
60. Viljanen M, Savilahti E, Haahtela T, et al. (2005) Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60, 494-500. (Pubitemid 40332976)
61. Kukkonen K, Kuitunen M, Haahtela T, et al. (2010) High intestinal IgA associates with reduced risk of IgE-associated allergic diseases. Pediatr Allergy Immunol 21, 67-73.
62. de Jonge JD, Ezendam J, Knippels LMJ, et al. (2008) Lactobacillus casei Shirota does not decrease the food allergic response to peanut extract in Brown Norway rats. Toxicology 249, 140-145.
63. Kopp MV, Hennemuth I, Heinzmann A, et al. (2008) Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121, E850-E856.
64. Rose CE, Sung SSJ & Fu SM (2003) Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10, 273-288. (Pubitemid 39004255)
65. Steensberg A, Fischer CP, Keller C, et al. (2003) IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285, E433-E437. (Pubitemid 36899719)